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 Background: Understanding successful and unsuccessful behavioural treatment for 
pain is essential. Aims: We carried out a retrospective survey of 130 people who had 
undergone pain rehabilitation based on Acceptance and Commitment Therapy, 
aiming to identify factors associated with non-response. Method: The sample was 
selected using the reliable change index to define ‘responders’ and ‘non-responders’ 
to key outcome measures. We surveyed a range of treatment-related, systemic, 
practical and personal factors that may have affected their treatment, and then 
compared ‘non-responders’ to ‘responders’, controlling for factors that might not be 
causal or specific to non-response. Results: Logistic regression analysis showed 
two themes that distinguished the groups, ‘People outside programme’ and 
‘Emotional state’. Conclusions: These data have clinical implications, as such 
factors can be addressed directly or incorporated into an assessment of treatment 
‘readiness’. This study introduced a novel methodology for the investigation of pain 
treatment response, which allowed a broad study of clinically relevant variables, but 
with greater rigour than conventional self-reports of ‘helpful factors’ in treatment.  
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Introduction 
To improve treatments for chronic pain, understanding treatment failure is necessary. 
Psychological treatment studies for pain typically report significant group mean 
improvements, yet these groups will include many individuals who had no 
improvement. A review of psychological treatment for chronic pain advised attention 
to adverse events and the use of responder analyses (Morley, Williams & Eccleston, 
2013), where the classification of individual patients as treatment responders, or non-
responders, allows researchers to go beyond mean scores in the search for 
predictors of treatment response.   
 
Eliot (2010) identified three key methodological approaches in therapy process 
research. ‘Process-outcome’ uses in-therapy variables to predict outcomes. 
‘Sequential process’ analyses the events within and between therapy sessions to 
establish dependencies between therapist and client responses. Finally, the ‘helpful 
factors’ design directly asks recipients of treatment about their opinion of effective 
therapeutic factors.  
 
The ‘helpful factors’ design is attractive as it stays close to the patient’s experience, 
and can be done in routine treatment settings. Recent examples include qualitative 
analyses of interviews and diary entries. However, the potential power of this design 
is restricted by the limitations of self-report, as patients’ insight into the causes of 
their own therapeutic response may be limited.  
 
Results from ‘helpful factors’ research depends on which participants are asked. For 
instance, barriers to treatment are best explored in those who have most evidently 
encountered them (i.e. non-responders). However, ‘helpful factors’ studies usually 
select samples of patients who have experienced a treatment, and do not 
discriminate whether these individuals benefited from treatment or not.  
 
We extended the value of ‘helpful factors’ design by controlling for difficulties in self-
report, in the context of intensive, residential, group-based Acceptance and 
Commitment Therapy (ACT) treatment for chronic pain. Exploring the reasons for 
treatment non-response, we asked patients about a range of individual, systemic and 
therapy-related factors that may have negatively affected their treatment outcome. 
The factors reflected patients’ reports and therapist formulations for potential 
treatment success or failure. Responses from ‘responders’ and ‘non-responders’ 
were compared in order to control for factors that patients did not like, but that were 
unrelated to outcome. We hypothesised that differences would exist between 
responders’ and non-responders’ views of helpful and unhelpful factors in treatment. 
 
Method 
Participants 
A retrospective questionnaire was sent to 130 people with chronic, non-malignant 
pain who had consecutively attended intensive, residential, psychologically-based 
pain rehabilitation treatment (3 or 4 weeks) at a national specialist service. This 
included 65 treatment non-responders (69% female) and 65 responders (83% 
female), with a heterogeneous group of musculoskeletal pain diagnoses. Patients 
were clinically selected for treatment, and thus had sufficient English and cognitive 
abilities to engage in group treatment. No further inclusion or exclusion criteria were 
applied. 
 
Participants completed treatment between 5 and 43 months prior to the study (Mdn = 
29), delivered by a team of Clinical Psychologists, Physiotherapists and Occupational 
Therapists, all specialists in pain rehabilitation. Participants completed standard 
outcome measures pre- and post-treatment, and at a three-month follow-up. 
 
Procedure 
The study received Ethical approval from the relevant NHS (REC reference: 
14/EE/0213; IRAS project ID: 146652) and University Ethics Committees (14-050), 
and the local Hospital R&D Committee.  
 
Participants were identified by reviewing consecutive cases in a treatment outcome 
database. We included 65 ‘responders’ and 65 ‘non-responders’, identified using the 
Reliable Change Index (RCI). The sample size was decided pragmatically, based on 
the size of our database and anticipated return rates. The questionnaire package 
was posted with a £10 voucher. A reminder letter was sent after two weeks.  
 
Defining non-responders 
‘Non-responders’ and ‘responders’ were classified using the RCI (Jacobson, Roberts, 
Berns & McGlinchy, 1999), which indicates when the magnitude of change seen is 
unlikely to be due to chance or measurement imprecision (see [Vowles & 
McCracken, 2008] for formula). This differs from clinically significant change, which is 
defined by the number of participants returning to a ‘normal’ or ‘non-clinical’ range. 
However, this is less appropriate for chronic pain, where ‘recovery’ is not expected. 
We looked at RCI inspecting three core clinical outcomes, at pre-treatment and three 
month follow up: overall disability, pain-related fear, and depression. ‘Non-
responders’ were those who did not achieve reliable change in all domains; 
‘responders’ achieved a reliable change in one or more domains.  
 
Measures  
Routine outcome measures were used to compute RCI. For disability, we used the 
total score from the Sickness Impact Profile (SIP); for pain-related fear, a total score 
of the Pain Anxiety Symptoms Scale (PASS); for depression, either the symptom 
severity subscale of the British Columbia Major Depression Inventory (BCMDI) or the 
total score from the Patient-Health Questionnaire (PHQ-9) was used. Patients 
treated prior to December 2011 (65.3%) completed the BCMDI, whereas those who 
attended later completed the PHQ-9.  
 
Novel ‘treatment factors’ item set 
We aimed to survey factors related to the individual, their context, and the therapy 
itself. To the authors’ knowledge, no instrument that covers these domains exists. 
The process of design aimed at creating items that closely reflected patient and 
therapist concerns, which could be structured by subscales. 
 
An initial item set was generated, based on the authors’ clinical experience and the 
results of a clinical case note audit examining treatment response in a sample of 30 
severely disabled patients with chronic pain. We then reviewed 50 ‘patient 
satisfaction’ forms where patients are invited to describe helpful aspects of the 
service. The proposed item set was circulated to the clinical team, at a national 
specialist in pain rehabilitation.  
 
The final set included 80 items. The broad focus necessitated different response 
formats for certain sets of items. For example, a 7-point scale ranging from “1” (very 
unhelpful) to “7” (very helpful) was used for items such as “being away from my 
normal routine”. In contrast, a scale from “1” (very untrue of me) to “7” (very true of 
me) was used for items such as “I was personally motivated to engage in treatment”. 
We grouped these items into six subscales; Change in routine; Communication and 
trust; Emotional state; Group climate; Medical interference; People outside 
programme.  
 
Data Analysis 
We explored themes by groups of thematically related Items. We considered the 
internal consistency of items within the pre-defined ‘subscales’, deleting items if they 
contributed to an unsatisfactory alpha. The remaining items resulted in internally 
consistent subscales (Cronbach’s α .79-.94) that were used as independent variables 
in a logistic regression analysis, with Response Group (responder or non-responder) 
as the dependent variable. The data were screened to ensure that it satisfied the 
assumptions of logistic regression.  
 
Results 
Responder analysis 
The responder analysis indicated that a reliable change was observed in at least one 
domain for 56.8% of cases. Split by outcome measure, a reliable change was found 
for 34.2% of patients on the BCMDI, 22.0% on the PHQ9, 30.9% on the PASS, and 
43.9% on the SIP.  
 
Demographics 
Of 130 questionnaires sent, nine were returned due to incorrect addresses; 75 were 
successfully returned (62%). This included 40 non-responders (53.3%; 26 female; M 
age 42.85; Mdn pain 114 months), and 35 responders (24 female; M age 45.38; Mdn 
pain 71 months). Groups were similar on baseline demographics, although 
responders reported higher disability (p<.01) and pain-related fear (p<.05). 
 
Logistic regression  
The regression model accounted for a significant amount of variance (p<.01), 
successfully classifying 70% of the cases overall (60% of responders and 80% of 
non-responders). Coefficients are displayed in Table 1. Two variables significantly 
predicted Response Group: Emotional State, and People Outside of Programme. 
Being a non-responder was associated with lower reports of bothersome emotional 
states, and with greater reported interference from people outside of the programme.  
 
Table 1. Logistic regression coefficients, with variables below as predictors of 
Response Group (non-responder or responder) 
 Wald Χ2 p OR 95% CI  
Emotional state 5.82 .02 0.39 [0.18, 0.84] 
People outside of programme 4.24 .04 1.62 [1.02, 2.56] 
Medical interference 3.11 .08 1.52 [0.95, 2.42] 
Change in routine 0.56 .45 0.79 [0.42, 1.46] 
Communication and trust 0.91 .34 0.59 [0.20, 1.73] 
Group climate 0.27 .60 1.11 [0.74, 1.67] 
p < .05 represented by bold type. OR, odds ratio; CI, confidence interval.  
 
Discussion 
We surveyed a group of patients who did not respond to pain rehabilitation treatment. 
‘Non-responders’ reported that their treatment was negatively affected by people 
outside of treatment, and paradoxically that they were experiencing fewer distressing 
emotional states at the time of the programme, compared to the ‘responder’ control 
group.  
 
To extend traditional approaches to studying treatment process, our design permitted 
examination of a range of clinically relevant factors, and introduced a comparison 
group. Certain factors that non-responders cited as ‘not helpful’ in treatment were 
endorsed equally by responders, indicating the value of the controlled comparison. 
Our design responds to calls for research using responder analysis in the pain 
literature (Morley et al., 2013), and for practitioner-oriented research in the cognitive 
behavioural therapy literature (McMain, Newman, Segal & DeRubeis, 2015) 
 
Non-responders reported that others outside of the programme were physically or 
emotionally abusive, or that they were worried about such abuse. They reported 
more difficult communications with others. It might seem obvious that ongoing 
interpersonal adversity would affect treatment, but this is seldom discussed in the 
more theoretically-oriented treatment process literature. 
 
Contrastingly, non-responders also reported lower levels of emotions such as guilt, 
frustration and sadness at the time of treatment. It seems that the non-responders 
were less distressed by the treatment experience. Although this may seem 
counterintuitive, this echoes theoretical and empirical accounts from ACT-based pain 
rehabilitation. For instance, positive treatment outcomes are related to patients’ 
ability to openly accept, and avoid suppression of, emotions in general (McCracken 
and Gutierrez-Martinez, 2011). Thus, the current study lends weight to previous 
findings indicating that enhanced emotional openness during ACT treatment (and 
thus increased experience of distress) can be associated with treatment response.  
 
These findings have potential clinical implications – for example, psychosocial 
adversity might be episodic or open to intervention. Assessing clinicians can benefit 
from knowing that high reported distress is not necessarily a barrier to successful 
treatment. Thus, there may be an argument for focusing treatment efforts on the 
social and family environment, as is now commonplace in interventions for psychotic 
conditions. Also, clinicians often intuitively assess whether it is ‘the right time’ for a 
patient to undertake treatment, given the patient’s overall state and circumstances. 
The results from this study add credence to the clinical assessment of ‘psychosocial 
stability’, but add the counterintuitive observation that reporting intense negative 
emotional states need be no barrier to successful ACT treatment. 
 
This study was preliminary and has several limitations. Our method of combining 
single items into ‘subscales’ was improvisational, rather than principled. However, in 
the absence of measures that reflected the wide range of factors cited by patients 
and clinicians, this approach was warranted. Similarly, we were unable to look at 
clinically significant change, as normative scores are not available and return to sub-
clinical levels is not expected for this population. Our findings may also be limited by 
the retrospective nature of participants’ reports and sample size. Prospectively 
employing this method in a treatment setting seeing a higher volume of patients 
would overcome this, whilst enabling exploration of factors related to specific 
outcome domains. 
 
In summary, we surveyed treatment non-responders and compared their responses 
to responders. This was a methodological innovation that, arguably, allowed the 
study of a wide range of treatment factors with the rigour of a controlled design. The 
results included theoretically relevant and counterintuitive findings that seemed to 
vindicate the design. 
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